DIMENSIONAL FUND ADVISORS LP - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,221
-16.6%
11,7530.0%0.00%
Q2 2023$17,0420.0%11,7530.0%0.00%
Q1 2023$17,042
+85110.0%
11,7530.0%0.00%
Q4 2022$20
-99.9%
11,753
+17.5%
0.00%
Q3 2022$20,000
-90.6%
10,003
-96.5%
0.00%
Q2 2022$212,000
-94.0%
284,956
-30.0%
0.00%
-100.0%
Q1 2022$3,540,000
-40.4%
406,946
+9.6%
0.00%
-50.0%
Q4 2021$5,943,000
-2.1%
371,222
+12.6%
0.00%0.0%
Q3 2021$6,068,000
+16.1%
329,633
-12.0%
0.00%0.0%
Q2 2021$5,227,000
+3.7%
374,443
+9.3%
0.00%0.0%
Q1 2021$5,041,000
+3.9%
342,506
+36.9%
0.00%0.0%
Q4 2020$4,852,000
+88.3%
250,197
+8.3%
0.00%
+100.0%
Q3 2020$2,577,000
-11.0%
231,009
+7.9%
0.00%0.0%
Q2 2020$2,897,000
+80.3%
214,155
+7.7%
0.00%0.0%
Q1 2020$1,607,000
+7.5%
198,861
+27.9%
0.00%0.0%
Q4 2019$1,495,000
+14.6%
155,480
+26.4%
0.00%0.0%
Q3 2019$1,304,000
+6.5%
123,005
+15.6%
0.00%
Q2 2019$1,224,000
+434.5%
106,403
+495.5%
0.00%
Q1 2019$229,00017,8690.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders